Top Markets
#1 DogBull DogBull +104.63%
#2 Siacoin Siacoin +51.82%
#3 ADO Protocol ADO Protocol +46.30%
#4 MarsCoin MarsCoin +42.67%
#5 UnifAI Network UnifAI Network +40.36%
#6 Magma Finance Magma Finance +26.28%
#7 Useless Coin Useless Coin +23.17%
#8 Ontology Gas Ontology Gas +20.50%
#9 Cash Cat Cash Cat +17.73%
#10 Apertum Apertum +14.66%
Coin of the day
DogBull DogBull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Rang in Aktien #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Aktienkurs
$7.15
Marktkapitalisierung
$313.60M
Veränderung (1 Tag)
-2.12%
Veränderung (1 Jahr)
-84.14%
Land
DE
Handel Anbio Biotechnology Class A Ordinary Shares (NNNN)

Kategorie

Healthcare
Preis NNNN mit Marktkapitalisierung von B
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares
NNNN
$7.15
Marktkapitalisierung von Anbio Biotechnology Class A Ordinary Shares(NNNN)
Marktkapitalisierung: $313.60M
Mit Stand September 2026 hat Anbio Biotechnology Class A Ordinary Shares eine Marktkapitalisierung von $313.60M. Das macht Anbio Biotechnology Class A Ordinary Shares laut unseren Daten zum 16102nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Anbio Biotechnology Class A Ordinary Shares von 2025 bis 2026
NNNN im Vergleich zu den Top 5 der beliebtesten stocks
Preis für NNNN Vermögenswert B Marktkapitalisierung von B Ergebnisse
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares
$119,833 $313.60M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +1,677,057.39%
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares
$108,872 $313.60M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,523,653.63%
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares
$91,515.86 $313.60M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,280,737.81%
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares
$84,739.30 $313.60M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,185,894.38%
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares
$62,295.85 $313.60M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +871,780.36%